Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple sclerosis treatment 2001.

L A Rolak1

  • 1Marshfield Clinic, WI 54449, USA.

Neurologic Clinics
|July 27, 2001
PubMed
Summary
This summary is machine-generated.

New multiple sclerosis (MS) drug trials are expensive, limiting research questions. Physicians rely on clinical judgment for current treatments while many new MS therapies are in development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Leonard Wood: the physician who was almost President of the United States.

Journal of medical biography·2001
Same author

Migraine versus multiple sclerosis.

Headache·2001
Same author

Who was Ondine and what was his curse?

Journal of child neurology·1996
Same author

IFNB in MS.

Neurology·1996
Same author

Cerebrospinal fluid in acute optic neuritis: experience of the optic neuritis treatment trial.

Neurology·1996
Same author

The diagnosis of multiple sclerosis.

Neurologic clinics·1996
Same journal

Sports Neurology.

Neurologic clinics·2026
Same journal

Sports-Related Peripheral Nerve Injuries.

Neurologic clinics·2026
Same journal

Active Rehabilitation and Return to Play in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Autonomic Assessment and Management in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Management of Vestibular Symptoms in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Neuropsychological Assessment in Sport-Related Concussion: Evidence, Controversies, and Clinical Applications.

Neurologic clinics·2026
See all related articles

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Multiple Sclerosis (MS) drug development is costly, involving extensive MR imaging and clinical data.
  • The high expense of clinical trials limits the scope of research questions that can be addressed.
  • Physicians currently rely on clinical expertise to guide treatment decisions for MS patients.

Purpose of the Study:

  • To provide an overview of the current landscape of multiple sclerosis therapeutics.
  • To highlight the challenges and limitations in drug development for MS.
  • To discuss the future potential of novel agents in MS therapy.

Main Methods:

  • Review of existing literature on MS drug trials and therapeutic agents.
  • Analysis of the economic and logistical factors influencing MS research.

Related Experiment Videos

  • Discussion of emerging drug candidates for MS treatment.

    • Main Results:

    • Current MS drug trials are resource-intensive, restricting the number of investigational questions.
    • A limited number of established drugs are expected to dominate MS therapy in the near future.
    • Over forty new agents are under investigation, indicating significant future therapeutic advancements.

    Conclusions:

    • The high cost of MS drug trials necessitates careful selection of research objectives.
    • Clinical judgment remains crucial for optimizing patient treatment in the interim.
    • The pipeline of novel MS therapies offers substantial promise for improved patient outcomes.